Transgender people and communities, including nonbinary people, have specific needs within harm reduction programs.
Breadcrumb
- Home
- Resources and Tools
Resources and Tools
This month’s Connecting Care episode discusses the impact of structural racism at the intersection of HIV and OUD care and opportunities to think outside of the box to effect change.
For Boston Health Care for the Homeless nurse Megan Sonderegger, providing client-centered care means literally meeting her clients where they are.
In recent years, the gap in the rate of opioid overdoses among Black and white Americans has narrowed significantly, with increases in Black mortality driven in part by the addition of synthetic opioids to other drugs.
There are so many factors that impact adherence and health outcomes. During this Connecting Care podcast, Drs. Alex Walley, Jessica Taylor, and Sim Kimmel discuss HIV prevention and treatment among people who inject drugs.
This technical package, a collaborative effort between CDC and NASTAD, provides a broad framework as well as evidence-informed strategies and approaches to support the planning, design, implementation, and sustainability of new and existing syringe services programs (SSPs).
Opioid agonist treatment (OAT) is the provision of medications (methadone and buprenorphine) that activate the opioid receptors to prevent withdrawal and reduce cravings for opioids.
This publication, part of SAMHSA's Evidence Based Resource Guide series, addresses the co-occurrence of HIV and mental illness and/or SUD.
Pagination
- Previous page ‹‹
- Page 2
- Next page ››